关注
Yuki Togashi
Yuki Togashi
Pathology Project for Molecular Targets, The Cancer Institute, JFCR
在 jfcr.or.jp 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
RET, ROS1 and ALK fusions in lung cancer
K Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ...
Nature medicine 18 (3), 378-381, 2012
15992012
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer
K Takeuchi, YL Choi, Y Togashi, M Soda, S Hatano, K Inamura, S Takada, ...
Clinical Cancer Research 15 (9), 3143-3149, 2009
8982009
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7562021
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts
K Takeuchi, YL Choi, M Soda, K Inamura, Y Togashi, S Hatano, ...
Clinical Cancer Research 14 (20), 6618-6624, 2008
6212008
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
K Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ...
Journal of thoracic oncology 3 (1), 13-17, 2008
5912008
Identification of novel isoforms of the EML4-ALK transforming gene in non–small cell lung cancer
YL Choi, K Takeuchi, M Soda, K Inamura, Y Togashi, S Hatano, ...
Cancer research 68 (13), 4971-4976, 2008
5752008
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ...
Modern Pathology 22 (4), 508-515, 2009
5542009
KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only
Y Togashi, M Soda, S Sakata, E Sugawara, S Hatano, R Asaka, ...
PloS one 7 (2), e31323, 2012
3132012
Identification of anaplastic lymphoma kinase fusions in renal cancer: Large‐scale immunohistochemical screening by the intercalated antibody‐enhanced polymer method
E Sugawara, Y Togashi, N Kuroda, S Sakata, S Hatano, R Asaka, ...
Cancer 118 (18), 4427-4436, 2012
1552012
Frequent BCOR aberrations in extranodal NK/T‐Cell lymphoma, nasal type
A Dobashi, N Tsuyama, R Asaka, Y Togashi, K Ueda, S Sakata, S Baba, ...
Genes, Chromosomes and Cancer 55 (5), 460-471, 2016
1282016
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma
K Takeuchi, M Soda, Y Togashi, Y Ota, Y Sekiguchi, S Hatano, R Asaka, ...
Haematologica 96 (3), 464, 2011
1162011
Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1–ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification
K Takeuchi, M Soda, Y Togashi, E Sugawara, S Hatano, R Asaka, ...
Clinical Cancer Research 17 (10), 3341-3348, 2011
1142011
let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis
K Inamura, Y Togashi, K Nomura, H Ninomiya, M Hiramatsu, Y Satoh, ...
Lung cancer 58 (3), 392-396, 2007
1072007
MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts
Y Togashi, A Dobashi, S Sakata, Y Sato, S Baba, A Seto, H Mitani, ...
Modern Pathology 31 (6), 934-946, 2018
852018
Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene
H Kusano, Y Togashi, J Akiba, F Moriya, K Baba, N Matsuzaki, Y Yuba, ...
The American journal of surgical pathology 40 (6), 761-769, 2016
782016
Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t (6; 11) translocation
K Inamura, M Fujiwara, Y Togashi, K Nomura, H Mukai, Y Fujii, ...
The American journal of surgical pathology 36 (1), 35-42, 2012
782012
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
K Takeuchi, Y Togashi, Y Kamihara, T Fukuyama, H Yoshioka, A Inoue, ...
Annals of Oncology 27 (1), 185-192, 2016
612016
DOCK2 is involved in the host genetics and biology of severe COVID-19
H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ...
Nature 609 (7928), 754-760, 2022
582022
ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern
K Sakamoto, H Nakasone, Y Togashi, S Sakata, N Tsuyama, S Baba, ...
International journal of hematology 103, 399-408, 2016
372016
A second update on mapping the human genetic architecture of COVID-19
M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ...
Nature 621 (7977), E7-E26, 2023
272023
系统目前无法执行此操作,请稍后再试。
文章 1–20